Lack of renal dopamine D5 receptors promotes hypertension

Journal of the American Society of Nephrology

Volumn 22, Issue 1, 2011, Pages 82-89

  Asico, Laureano ^a   Zhang, Xiaojie ^b   Jiang, Jifu ^c   Cabrera, David ^d   Escano, Crisanto S ^a   Sibley, David R ^d   Wang, Xiaoyan ^a   Yang, Yu ^a   Mannon, Roslyn ^e   Jones, John E ^a   Armando, Ines ^a   Jose, Pedro A ^a  

^a CHILDREN S RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; DOPAMINE 5 RECEPTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DISEASE COURSE; HOMEOSTASIS; HYPERTENSION; KIDNEY; KIDNEY TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALT LOADING; SHAM FEEDING; WILD TYPE;

EID: 78651395292     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010050533     Document Type: Article

References (62)

1. Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA: Functional genomics of the dopaminergic system in hypertension. Physiol Genomics 19: 233-246, 2004
2. Banday AA, Lokhandwala MF: Dopamine receptors and hypertension. Curr Hypertens Rep 10: 268-275, 2008
3. Aperia A: Intrarenal dopamine: A key signal in the interactive regulation of sodium metabolism. Annu Rev Physiol 62: 621-647, 2000 (Pubitemid 30618277)
4. van den Buuse M: Role of the mesolimbic dopamine system in cardiovascular homeostasis: Stimulation of the ventral tegmental area modulates the effect of vasopressin on blood pressure in conscious rats. Clin Exp Pharmacol Physiol 25: 661-668, 1998
5. Sowers JR, Viosca SP, Windsor C, Korenman SG: Influence of dopaminergic mechanisms on 24-hour secretory patterns of prolactin, luteinizing hormone and testosterone in recumbent men. J Endocrinol Invest 6: 9-15, 1983 (Pubitemid 13127998)
6. Carey RM, Sen S: Recent progress in the control of aldosterone secretion. Recent Prog Horm Res 42: 251-296, 1986
7. Roitman MF, Schafe GE, Thiele TE, Bernstein IL: Dopamine and sodium appetite: Antagonists suppress sham drinking of NaCl solutions in the rat. Behav Neurosci 111: 606-611, 1997
8. +-ATPase during high-salt diet in young but not in adult rats. Am J Physiol 275: G1317-G1323, 1998
9. Felder RA, Seikaly MG, Cody P, Eisner GM, Jose PA: Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats. Hypertension 15: 560-569, 1990 (Pubitemid 20187600)
10. Siragy HM, Felder RA, Howell NL, Chevalier RL, Peach MJ, Carey RM: Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am J Physiol 257: F469-F477, 1989
11. Chen CJ, Lokhandwala MF: An impairment of renal tubular DA 1 receptor function as the causative factor for diminished natriuresis to volume expansion in spontaneously hypertensive rats. Clin Exp Hypertens A 14: 615-628, 1992
12. Sunahara RK, Guan HC, O'Dowd BF, Seeman P, Laurier LG, Ng G, George SR, Torchia J, Van Tol HH, Niznik HB: Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature 350: 614-661, 1991
13. Tiberi M, Caron MG: High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype. J Biol Chem 269: 27925-27931, 1994
14. Zheng S, Yu P, Zeng C, Wang Z, Yang Z, Andrews PM, Felder RA, Jose PA: Gα12- and Gα13-protein subunit linkage of D5 dopamine receptors in the nephron. Hypertension 41: 604-610, 2003
15. Amenta F: Light microscope autoradiography of peripheral dopamine receptor subtypes. Clin Exp Hypertens 19: 27-41, 1997
16. Hollon TR, Bek MJ, Lachowicz JE, Ariano MA, Mezey E, Ramachandran R, Wersinger SR, Soares-da-Silva P, Liu ZF, Grinberg A, Drago J, Young WS 3rd, Westphal H, Jose PA, Sibley DR: Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. J Neurosci 22: 10801-10810, 2002
17. Yang Z, Asico LD, Yu P, Wang Z, Jones JE, Escano CS, Wang X, Quinn MT, Sibley DR, Romero GG, Felder RA, Jose PA: D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regulatory Integrative Comp Physiol 290: R96-R104, 2006
18. Zeng C, Yang Z, Wang Z, Jones J, Wang X, Altea J, Mangrum AJ, Hopfer U, Sibley DR, Eisner GM, Felder RA, Jose PA: Interaction of angiotensin II type 1 and D5 dopamine receptors in renal proximal tubule cells. Hypertension 45: 804-810, 2005 (Pubitemid 40418385)
19. Li H, Armando I, Yu P, Escano C, Mueller SC, Asico L, Pascua A, Lu Q, Wang X, Villar VA, Jones JE, Wang Z, Periasamy A, Lau YS, Soaresda- Silva P, Creswell K, Guillemette G, Sibley DR, Eisner G, Gildea JJ, Felder RA, Jose PA: Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells. J Clin Invest 118: 2180-2189, 2008
20. Amenta F, Ricci A, Tayebati SK, Zaccheo D: The peripheral dopaminergic system: morphological analysis, functional and clinical applications. Ital J Anat Embryol 107: 145-167, 2002
21. Amenta F, Barili P, Bronzetti E, Ricci A: Dopamine D1-like receptor subtypes in the rat kidney: A microanatomical study. Clin Exp Hypertens 21: 17-23, 1999 (Pubitemid 29084617)
22. Yao LP, Huque E, Baraniuk J, Carey RM, Felder RA, Jose PA: Dopamine receptor subtype expression (D1A and D1B) in rat nephron segments [Abstract]. J Investig Med. 44: 305A, 1996
23. Escano CS, Armando I, Wang X, Asico LD, Pascua A, Yang Y, Wang Z, Lau YS, Jose PA: Renal dopaminergic defect in C57Bl/6J mice. Am J Physiol Regul Integr Comp Physiol 297: R1660-R1669, 2009
24. Olsen NV, Hansen JM, Ladefoged SD, Fogh-Andersen N, Leyssac PP: Renal tubular reabsoption of sodium and water during infusion of low-dose dopamine in normal mam. Clin Sci 78: 503-507, 1990
25. Vieira-Coelho MA, Gomes P, Serrão MP, Soares-da-Silva P: D1-like dopamine receptor activation and natriuresis by nitrocatechol COMT inhibitors. Kidney Int 59: 1683-1694, 2001
26. Gildea JJ, Wang X, Jose PA, Felder RA: Differential D1 and D5 receptor regulation and degradation of the angiotensin type 1 receptor. Hypertension 51: 360-366, 2008
27. Demchyshyn LL, McConkey F, Niznik HB: Dopamine D5 receptor agonist high affinity and constitutive activity profile conferred by carboxyl-terminal tail sequence. J Biol Chem 275: 23446-23455, 2000
28. Baines AD, Ho P, Drangova R: Proximal tubular dopamine production regulates basolateral Na-K-ATPase. Am J Physiol 262: F566-F571, 1992
29. +-ATPase activity in rat proximal convoluted tubule segments. Am J Physiol Renal Fluid Electrolyte Physiol 252: F39-F45, 1987
30. Bacic D, Kaissling B, McLeroy P, Zou L, Baum M, Moe OW: Dopamine acutely decreases apical membrane Na/H exchanger NHE3 protein in mouse renal proximal tubule. Kidney Int 64: 2133-2141, 2003
31. Grider JS, Ott CE, Jackson BA: Dopamine D1 receptor-dependent inhibition of NaCl transport in the rat thick ascending limb: Mechanism of action. Eur J Pharmacol 473: 185-190, 2003
32. 3-exchanger in immortalized SHR proximal tubular epithelial cells. Am J Physiol Renal Physiol 286: F1120-F1126, 2004
33. Chen C-J, Apparsundaram S, Lokhandwala MF: Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats. J Pharmacol Exp Ther 256: 486-491, 1991
34. Clark KL, Hilditch A, Robertson MJ, Drew GM: Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anesthetized dog. J Hypertens 9: 1143-1150, 1991
35. Sheikh-Hamad D, Wang Y-P, Jo OD, Yanagawa N: Dopamine antagonizes the actions of angiotensin II in renal brush-border membrane. Am J Physiol 264: F737-F743, 1993
36. Efendiev R, Budu CE, Cinelli AR, Bertorello AM, Pedemonte CH: Intracellular Na+ regulates dopamine and angiotensin II receptors availability at the plasma membrane and their cellular responses in renal epithelia. J Biol Chem 278: 28719-28726, 2003
37. + exchanger in spontaneously hypertensive rats. Am J Physiol 261: F526-F536, 1991
38. Khan F, Spicarová Z, Zelenin S, Holtbäck U, Scott L, Aperia A: Negative reciprocity between angiotensin II type 1 and dopamine D1 receptors in rat renal proximal tubule cells. Am J Physiol Renal Physiol 295: F1110-F1116, 2008
39. Banday AA, Lokhandwala MF: Oxidative stress-induced renal angiotensin AT1 receptor upregulation causes increased stimulation of sodium transporters and hypertension. Am J Physiol Renal Physiol 295: F698-F706, 2008
40. 2 upregulates arteriolar constrictions to angiotensin II by increasing the functional availability of AT1 receptors. Am J Physiol Heart Circ Physiol 295: H835-H841, 2008
41. Liu D, Gao L, Roy SK, Cornish KG, Zucker IH: Role of oxidant stress on AT1 receptor expression in neurons of rabbits with heart failure and in cultured neurons. Circ Res 103: 186-193, 2008
42. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, Smithies O, Le TH, Coffman TM: Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A 103: 17985-17989, 2006
43. Janssen BJ, De Celle T, Debets JJ, Brouns AE, Callahan MF, Smith TL: Effects of anesthetics on systemic hemodynamics in mice. Am J Physiol Heart Circ Physiol 287: H1618-H1624, 2004
44. Tank J, Obst M, Diedrich A, Brychta RJ, Blumer KJ, Heusser K, Jordan J, Luft FC, Gross V: Sympathetic nerve traffic and circulating norepinephrine levels in RGS2-deficient mice. Auton Neurosci 136: 52-57, 2007
45. Amenta F, Barili P, Bronzetti E, Felici L, Mignini F, Ricci A: Localization of dopamine receptor subtypes in systemic arteries. Clin Exp Hypertens 22: 277-288, 2000
46. Natarajan A, Han G, Chen SY, Yu P, White R, Jose P: The d5 dopamine receptor mediates large-conductance, calcium- and voltage-activated potassium channel activation in human coronary artery smooth muscle cells. J Pharmacol Exp Ther 332: 640-649, 2010
47. Ricci A, Amenta F, Bronzetti E, Felici L, Hussain T, Lokhandwala MF: Age-related changes of dopamine receptor protein immunoreactivity in the rat mesenteric vascular tree. Mech Ageing Dev 123: 537-546, 2002
48. Ricci A, Mignini F, Tomassoni D, Amenta F: Dopamine receptor subtypes in the human pulmonary arterial tree. Auton Autacoid Pharmacol 26: 361-369, 2006
49. White RE, Kryman JP, El-Mowafy AM, Han G, Carrier GO: cAMP-dependent vasodilators cross-activate the cGMP-dependent protein kinase to stimulate BK(Ca) channel activity in coronary artery smooth muscle cells. Circ Res 86: 897-905, 2000
50. Karlsson RM, Hefner KR, Sibley DR, Holmes A: Comparison of dopamine D1 and D5 receptor knockout mice for cocaine locomotor sensitization. Psychopharmacology 200: 117-127, 2008
51. 1 receptor subtype. Neurochem Res 32: 229-240, 2007
52. DiBona GF, Sawin LL: Renal nerves in renal adaptation to dietary sodium restriction. Am J Physiol 245: F322-F328, 1983
53. DiBona GF: Renal neural mechanisms in salt-sensitive hypertension. Blood Press Suppl 2: 81-87, 1995
54. Fujita M, And K, Nagae A, Fujita T: Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in salt-sensitive hypertension. Hypertension 50: 360-367, 2007
55. Crowley SD, Gurley SB, Oliiverio MI, Pazmino AK, Griffiths RM, Flannery PJ, Spurney RF, Kim H-S, Smithies O, Le TH, Coffman TM: Distinct roles for the kidney and the systemic tissues in blood pressure regulation by the renin-angiotensin system, J Clin Invest 115: 1092-1099, 2005
56. Allayee H, de Bruin TW, Dominguez KM, Cheng LS, Ipp E, Cantor RM, Krass KL, Keulen ET, Aouizerat BE, Lusis AJ, Rotter JI: Genome scan for blood pressure in Dutch dyslipidemic families reveals linkage to a locus on chromosome 4p. Hypertension 38: 773-778, 2001
57. Casari G, Barlassina C, Cusi D, Zagato L, Muirhead R, Righetti M, Nembri P, Amar K, Gatti M, Macciardi F, Binelli G, Bianchi G: Association of the alpha-adducin locus with essential hypertension. Hypertension 25: 320-326, 1995
58. Grandy DK, Allen LJ, Zhang Y, Magenis RE, Civelli O: Chromosomal localization of three human D5 dopamine receptor genes. Genomics 13: 968-973, 1992
59. Cohn DH, Shohat T, Yahav M, Ilan T, Rechavi G, King L, Shohat M: A locus for an autosomal dominant form of progressive renal failure and hypertension at chromosome 1q21. Am J Hum Genet 67: 647-651, 2000
60. Cooper RS, Luke A, Zhu X, Kan D, Adeyemo A, Rotimi C, Bouzekri N, Ward R, Rorimi C: Genome scan among Nigerians linking blood pressure to chromosomes 2, 3, and 19. Hypertension 40: 629-633, 2002
61. Cravchik A, Gejman PV: Functional analysis of the human D5 dopamine receptor missense and nonsense variants: differences in dopamine binding affinities. Pharmacogenetics 9: 199-206, 2002 (Pubitemid 29359002)
62. Zeng C, Wang D, Yang Z, Wang Z, Asico LD, Wilcox CS, Eisner GM, Welch WJ, Felder RA, Jose PA: Dopamine D1 receptor augmentation of D3 receptor action in rat aortic or mesenteric vascular smooth muscles. Hypertension 43: 673-679, 2004